Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 348

1.
2.

Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators.

Cancer. 2006 Apr 15;106(8):1708-14.

3.

Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE.

Park S, Meng MV, Elkin EP, Speight JL, DuChane J, Carroll PR.

J Urol. 2005 Nov;174(5):1802-7.

PMID:
16217291
4.

Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR.

J Urol. 2005 Apr;173(4):1126-31.

5.
6.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
7.

Prostate brachytherapy: a descriptive analysis from CaPSURE.

Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR; CaPSURE Investigators.

Brachytherapy. 2007 Apr-Jun;6(2):123-8.

PMID:
17434105
8.
9.

Trends of the primary therapy for patients with prostate cancer in Nara uro-oncological research group (NUORG): a comparison between the CaPSURE data and the NUORG data.

Tanaka N, Fujimoto K, Hirayama A, Yoneda T, Yoshida K, Hirao Y.

Jpn J Clin Oncol. 2010 Jun;40(6):588-92. doi: 10.1093/jjco/hyq008. Epub 2010 Mar 18.

PMID:
20299498
10.

Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.

Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR; CaPSURE Investigators.

J Urol. 2007 Aug;178(2):529-34; discussion 534. Epub 2007 Jun 13.

PMID:
17570425
11.

Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.

Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR.

Urology. 2007 Jul;70(1):106-10.

PMID:
17656218
12.

Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE.

Mehta SS, Lubeck DP, Sadetsky N, Pasta DJ, Carroll PR.

J Urol. 2004 Jan;171(1):215-9.

PMID:
14665879
13.
14.

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR.

J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24. Epub 2007 Oct 9.

PMID:
17925537
15.

Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.

Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators.

Prostate Cancer Prostatic Dis. 2008;11(3):280-7. Epub 2007 Sep 25.

PMID:
17893700
16.

Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR; Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE).

Cancer. 2008 Jan 15;112(2):307-14.

17.

Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.

Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):795-9. Epub 2005 May 31.

PMID:
15925452
18.

Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.

Dall'era MA, Hosang N, Konety B, Cowan JE, Carroll PR.

J Urol. 2009 Apr;181(4):1622-7; discussion 1627. doi: 10.1016/j.juro.2008.11.123. Epub 2009 Feb 23.

PMID:
19230923
19.

Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy.

Grossfeld GD, Li YP, P Lubeck DP, Carroll PR.

Urology. 2002 Sep;60(3 Suppl 1):57-62; discussion 62-3. Review.

PMID:
12231051
20.

Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.

Demanes DJ, Brandt D, Schour L, Hill DR.

Am J Clin Oncol. 2009 Aug;32(4):342-7. doi: 10.1097/COC.0b013e31818cd277.

PMID:
19398902

Supplemental Content

Support Center